Bulletin
Investor Alert

Gilead Sciences Inc.

NASDAQ: GILD

GO

Set Alerts

Find a Broker

Join TD Ameritrade

Market Index

Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Gilead Sciences Inc.

After Hours

GILD
/quotes/zigman/72849/composite

$

76.27

Change

+0.06 +0.08%

Volume

Volume 77,461

Oct 6, 2016, 7:57 p.m.

Quotes are delayed by 20 min

/quotes/zigman/72849/composite

Today's close

$ 77.57

$ 76.21

Change

-1.36 -1.75%

Day low

Day high

$76.08

$77.76

Open
Open: 77.38

52 week low

52 week high

$76.08

$111.11

Open

Market cap

$102.37B

Average volume

10.20M

P/E ratio

6.71

Rev. per Employee

$4.02M

EPS

11.35

Dividend

0.47

Div yield

2.47%

Ex dividend date

9/14/16

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gild

MarketWatch News on GILD

  1. Biotech stocks have plenty of catalysts around the corner

    1:28 p.m. Sept. 30, 2016

    - Michael Brush

  2. Gilead Sciences' stock falls 1.5% premarket after analyst downgrade

    8:52 a.m. Sept. 27, 2016

    - Tomi Kilgore

  3. Gilead Sciences stock price target cut to $94 from $112 at Leerink Partners

    7:21 a.m. Sept. 27, 2016

    - Tomi Kilgore

  4. Gilead Sciences downgraded to market perform at Leerink Partners

    7:21 a.m. Sept. 27, 2016

    - Tomi Kilgore

  7. video content Untreated: Hepatitis C, America's Prison Epidemic

    11:15 a.m. Sept. 13, 2016

    - WSJ.com

  8. This is the most expensive drug in America

    11:23 a.m. Sept. 3, 2016

    - Emma Court

  9. How Gilead ‘broke’ Obamacare

    3:35 p.m. Aug. 31, 2016

    - Tim Mullaney

  10. Pfizer's Medivation deal isn't new for drug maker

    3:48 p.m. Aug. 22, 2016

    - MarketWatch.com

  12. This beaten-down biotech stock is a cure for your portfolio

    9:14 a.m. Aug. 12, 2016

    - Michael Brush

  13. Merck revenue boosted by cancer, hepatitis drugs

    7:55 a.m. July 29, 2016

    - MarketWatch.com

  14. Dow tripped up by McDonald’s; Nasdaq hits 2016 high

    5:25 p.m. July 26, 2016

    - Sara Sjolin

  15. Here’s your second chance to buy into oil’s recovery

    10:03 a.m. July 26, 2016

    - Barbara Kollmeyer

  16. Gilead sales of hepatitis C drugs fall 19%

    4:48 p.m. July 25, 2016

    - MarketWatch.com

  18. Gilead shares slide 4% following product sales outlook cut

    4:14 p.m. July 25, 2016

    - Sue Chang

  19. Gilead cuts 2016 net product sales outlook to $29.5 bln-$30.5 bln

    4:13 p.m. July 25, 2016

    - Sue Chang

  20. Gilead Q2 adjusted EPS $3.08 vs estimate of $3.02

    4:10 p.m. July 25, 2016

    - Sue Chang

  21. Loading more headlines...
Get more info »

Where does this data come from?

Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.

Sentiment on GILD

Analyst Ratings

/news/nonmarketwatch/company/us/gild

Other News on GILD

  1. Gilead's Value Without Its HCV Franchise

    3:43 p.m. Today

    - Seeking Alpha

  2. Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

    3:39 p.m. Today

    - 247WallSt.com

  3. Biotechs getting roughed up; IBB down 2.4%

    3:32 p.m. Today

    - Seeking Alpha

  4. Gilead, AbbVie, Merck Face 'Black-Box Warning'

    11:58 a.m. Today

    - GuruFocus.com

  5. Singapore’s Temasek Hires Veteran Goldman Banker

    11:52 a.m. Today

    - The Wall Street Journal Interactive Edition

  6. Gilead Sciences Should Absolutely Not Split

    10:42 a.m. Today

    - Motley Fool

  7. Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

    8:59 a.m. Today

    - 247WallSt.com

  8. Valuation Dashboard: Healthcare - Update

    8:27 a.m. Today

    - Seeking Alpha

  9. Dividend Stocks Take a Hit

    5:20 p.m. Oct. 5, 2016

    - The Wall Street Journal Interactive Edition

  11. FDA Issues Warning on Hepatitis C Drugs

    3:27 p.m. Oct. 5, 2016

    - InvestorPlace.com

  12. Gilead Executives Might Think Small

    2:35 p.m. Oct. 5, 2016

    - Seeking Alpha

  13. Top 10 Net Payout Yields For October 2016

    2:19 p.m. Oct. 5, 2016

    - Seeking Alpha

  16. FDA Warns on Hepatitis C Drugs

    10:17 a.m. Oct. 5, 2016

    - The Wall Street Journal Interactive Edition

  18. My Portfolio Update: 43 Holdings, 3 New And 3 Sells

    4:31 p.m. Oct. 4, 2016

    - Seeking Alpha

  19. How Much Return Could Gilead Offer in the Next Year?

    6:03 p.m. Sept. 30, 2016

    - MarketRealist.com

  20. Allergan Enters the Attractive NASH Market

    6:03 p.m. Sept. 30, 2016

    - MarketRealist.com

  21. Loading more headlines...
/news/pressrelease/company/us/gild

Press Releases on GILD

  7. Gilead Prices $5 Billion of Senior Unsecured Notes

    10:01 p.m. Sept. 15, 2016

    - BusinessWire - BZX

  17. Kelly A. Kramer Joins Gilead Sciences’ Board of Directors

    8:55 a.m. Aug. 23, 2016

    - BusinessWire - BZX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto CREDIT CARDS
5 yr CD
1.2%
2 yr CD
0.8%
1 yr CD
0.6%
MMA $10K+
0.3%
MMA $50K+
0.4%
MMA Savings
0.3%
MMA Savings Jumbo
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 11.98% 11.98% 11.96%
Business 13.12% 13.12% 13.12%
Student 13.42% 13.42% 13.42%
Balance Transfer 14.39% 14.39% 14.36%
Airline 15.13% 15.13% 15.17%
Reward 15.30% 15.30% 15.26%
Cash Back 15.33% 15.33% 15.21%
Instant Approval 18.04% 18.04% 18.04%
Bad Credit 22.86% 22.86% 22.56%
Source:CreditCards.com
Link to MarketWatch's Slice.